Fatty acid beta oxidation enzyme HADHA is a novel potential therapeutic target in malignant lymphoma.
Yamamoto K, Abe S, Honda A, Hashimoto J, Aizawa Y, Ishibashi S, Takemura T, Hanagata N, Yamamoto M, Miura O, Kurata M, Kitagawa M.
Yamamoto K, et al. Among authors: ishibashi s.
Lab Invest. 2020 Mar;100(3):353-362. doi: 10.1038/s41374-019-0318-6. Epub 2019 Sep 16.
Lab Invest. 2020.
PMID: 31527828
Free article.